scispace - formally typeset
P

Paola Frati

Researcher at Sapienza University of Rome

Publications -  195
Citations -  2921

Paola Frati is an academic researcher from Sapienza University of Rome. The author has contributed to research in topics: Medicine & Health care. The author has an hindex of 23, co-authored 159 publications receiving 1916 citations. Previous affiliations of Paola Frati include American Board of Legal Medicine & University of Sannio.

Papers
More filters
Journal ArticleDOI

Healthcare-Associated Infections Due to Multidrug-Resistant Organisms: a Surveillance Study on Extra Hospital Stay and Direct Costs.

TL;DR: An accurate mapping of the clinical and economic impact of infections attributable to alert organisms demonstrating that infections due to multidrug-resistant organisms are associated with higher mortality, longer hospital stays, and increased costs is presented.
Journal ArticleDOI

The Evolution of Legislation in the Field of Medically Assisted Reproduction and Embryo Stem Cell Research in European Union Members

TL;DR: The authors reviewed the current legislation in the 28 EU member states trying to evaluate the different legislation paths adopted over the last 15 years and highlighting those EU countries with no specific legislation in place and MAR is covered by a general health Law and those countries in which there are no laws in this field but only “guidelines.”
Journal ArticleDOI

Evaluation of serum anti-Mullerian hormone levels to assess the ovarian reserve in women with severe endometriosis

TL;DR: It is suggested that AMH could be used in the follow-up of patients with endometriosis, in order to assess promptly the decrease of ovarian reserve, as an early sign of advanced ovarian depletion in young women.
Journal ArticleDOI

Acute Spinal Cord Injury: A Systematic Review Investigating miRNA Families Involved

TL;DR: Investigating the pathology and degree of clinical diagnosis and treatment strategies, the animal models that have allowed us to better understand this entity and the role of new diagnostic and prognostic tools such as miRNA could improve the ability to manage this pathological entity.